drugset / Trial / NCT02079649
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate two investigational ophthalmic solutions for reduction in ocular redness in subjects with allergic conjunctivitis.
Timeline
- Start
- 2014-04
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AL-53817 | Unknown | 0.1 % | Other |
| Subject | AL-78843 | Unknown | 0.03 % | Other |
| Comparator | Dexamethasone | Small molecule | 0.1 % | Other |